BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
42 results:

  • 1. Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast cancer.
    Zhang Y; Lv L; Zheng R; Xie R; Yu Y; Liao H; Chen J; Zhang B
    Breast Cancer Res; 2023 Jun; 25(1):75. PubMed ID: 37365643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic thyroid cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
    Wu J; Jiang Z; Liu Z; Yang B; Yang H; Tang J; Wang K; Liu Y; Wang H; Fu P; Zhang S; Liu Q; Wang S; Huang J; Wang C; Wang S; Wang Y; Zhen L; Zhu X; Wu F; Lin X; Zou J
    BMC Med; 2022 Dec; 20(1):498. PubMed ID: 36575513
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
    Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
    BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multikinase Inhibitors for the treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated thyroid cancer: Global Noninterventional Study (RIFTOS MKI).
    Brose MS; Smit JWA; Lin CC; Tori M; Bowles DW; Worden F; Shen DH; Huang SM; Tsai HJ; Alevizaki M; Peeters RP; Takahashi S; Rumyantsev P; Guan R; Babajanyan S; Ozgurdal K; Sugitani I; Pitoia F; Lamartina L
    Thyroid; 2022 Sep; 32(9):1059-1068. PubMed ID: 35950621
    [No Abstract]    [Full Text] [Related]  

  • 6. NOD1 activation promotes cell apoptosis in papillary thyroid cancer.
    Bai N; Liu C; Zhang X; Cheng Y; Hou D
    Pathol Res Pract; 2022 May; 233():153880. PubMed ID: 35430507
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single neonatal irradiation induces long-term gene expression changes in the thyroid gland, which may be involved in the tumorigenesis.
    Fujimoto N; Matsuu-Matsuyama M; Nakashima M
    Sci Rep; 2021 Dec; 11(1):23620. PubMed ID: 34880333
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma.
    van Iersel L; van Santen HM; Potter B; Li Z; Conklin HM; Zhang H; Chemaitilly W; Merchant TE
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28723. PubMed ID: 33037871
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
    Yamashita T; Kawaguchi H; Masuda N; Kitada M; Narui K; Hattori M; Yoshinami T; Matsunami N; Yanagihara K; Kawasoe T; Nagashima T; Bando H; Yano H; Hasegawa Y; Nakamura R; Kashiwaba M; Morita S; Ohno S; Toi M
    Invest New Drugs; 2021 Feb; 39(1):217-225. PubMed ID: 32833136
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Does the ATA Risk Stratification Apply to Patients with Papillary thyroid Microcarcinoma?
    Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
    World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
    Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
    Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Association of hyperthyroidism with differentiated thyroid cancer].
    Haraj NE; Ahandar H; El Aziz S; Chadli A
    Pan Afr Med J; 2016; 24():18. PubMed ID: 27583082
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
    Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
    Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
    Lopergolo A; Nicolini V; Favini E; Dal Bo L; Tortoreto M; Cominetti D; Folini M; Perego P; Castiglioni V; Scanziani E; Borrello MG; Zaffaroni N; Cassinelli G; Lanzi C
    J Clin Endocrinol Metab; 2014 Feb; 99(2):498-509. PubMed ID: 24276455
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Superior mediastinal dissection for papillary thyroid carcinoma: approaches and outcomes.
    Liu J; Wang X; Liu S; Liu X; Tang P; Xu Z
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):228-39. PubMed ID: 23900210
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
    Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
    Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.
    Brenner AJ; Cohen YC; Breitbart E; Bangio L; Sarantopoulos J; Giles FJ; Borden EC; Harats D; Triozzi PL
    Clin Cancer Res; 2013 Jul; 19(14):3996-4007. PubMed ID: 23589178
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
    Lang BH; Wong KP; Cheung CY; Wan KY; Lo CY
    Ann Surg Oncol; 2013 Apr; 20(4):1329-35. PubMed ID: 23104708
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Unstaged cancer in the United States: a population-based study.
    Merrill RM; Sloan A; Anderson AE; Ryker K
    BMC Cancer; 2011 Sep; 11():402. PubMed ID: 21936934
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Substernal goiters: incidence, surgical approach, and complications in a tertiary care referral center.
    Raffaelli M; De Crea C; Ronti S; Bellantone R; Lombardi CP
    Head Neck; 2011 Oct; 33(10):1420-5. PubMed ID: 21928414
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.